This portal consolidates clinical, molecular and survival data from 898 patients across three major trials (ACNS0331, ACNS0332, SJMB03). The portal integrates clinical data with genomic mutations and DNA methylomes, enabling in-depth analysis of tumor subgroups and survival outcomes.
